Jovana Milic, Stefano Calza, Luca Lazzarini, Mattia Cocchi, Federico Motta, Stefano Renzetti, Laura Sighinolfi, Michela Belli, Vera Todisco, Maddalena Albertini, Altea Gallerani, Marianna Menozzi, Gianluca Cuomo, Giuseppe Mancini, Chiara Mussi, Cristina Mussini, Andrea Calcagno, Giovanni Guaraldi
{"title":"Prevalence and risk factors of cognitive frailty in people with HIV.","authors":"Jovana Milic, Stefano Calza, Luca Lazzarini, Mattia Cocchi, Federico Motta, Stefano Renzetti, Laura Sighinolfi, Michela Belli, Vera Todisco, Maddalena Albertini, Altea Gallerani, Marianna Menozzi, Gianluca Cuomo, Giuseppe Mancini, Chiara Mussi, Cristina Mussini, Andrea Calcagno, Giovanni Guaraldi","doi":"10.1097/QAD.0000000000004352","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cognitive frailty (CF, the simultaneous presence of frailty and cognitive impairment) is recognized as a significant predictor of several adverse health outcomes. The objective of this study was to describe prevalence and risk factors for CF in people with HIV (PWH) >50 years.</p><p><strong>Methods: </strong>This was a cross-sectional observational study including PWH attending Modena HIV Metabolic Clinic (MHMC). Neurocognitive function was measured with Cogstate battery that comprises six domains. Each individual CogState raw score was transformed into z-score after correction for age and sex. Neurocognitive impairment was defined by total global deficit score >0.5. Frailty was assessed by 37-Item frailty index. Scores <0.25 were considered fit or >0.26 as frail.</p><p><strong>Results: </strong>A total of 1258 PWH were included, 916 (73%) were males, median age was 58 years, median time since HIV diagnosis was 27 years. The sample was divided into four groups (CF) based on the presence of frailty (F) and cognitive impairment (ICT): F + /ICT + , F + /ICT-, F-/ICT + , F-/ICT-. Age per 5-year increase (OR = 1.27, CI: 1.02-1.55, p = 0.022), nadir CD4 cell count (OR = 0.81, CI: 0.66 - 0.99, p = 0.042) and polypharmacy (OR = 3.47, CI: 2.00 - 6.00, p<0.001) were associated with CF after adjustment for time since HIV diagnosis, multimorbidity, depression and cumulative exposure to dolutegravir.</p><p><strong>Conclusion: </strong>CF prevalence in PWH >50 years was 6.8% and it is higher than what has been observed in the general population >65 years (1-4.4%). Nadir CD4 cell count and polypharmacy was associated with CF, suggesting an HIV specific contribution related to the development of this condition.</p>","PeriodicalId":7502,"journal":{"name":"AIDS","volume":" ","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"AIDS","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/QAD.0000000000004352","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Cognitive frailty (CF, the simultaneous presence of frailty and cognitive impairment) is recognized as a significant predictor of several adverse health outcomes. The objective of this study was to describe prevalence and risk factors for CF in people with HIV (PWH) >50 years.
Methods: This was a cross-sectional observational study including PWH attending Modena HIV Metabolic Clinic (MHMC). Neurocognitive function was measured with Cogstate battery that comprises six domains. Each individual CogState raw score was transformed into z-score after correction for age and sex. Neurocognitive impairment was defined by total global deficit score >0.5. Frailty was assessed by 37-Item frailty index. Scores <0.25 were considered fit or >0.26 as frail.
Results: A total of 1258 PWH were included, 916 (73%) were males, median age was 58 years, median time since HIV diagnosis was 27 years. The sample was divided into four groups (CF) based on the presence of frailty (F) and cognitive impairment (ICT): F + /ICT + , F + /ICT-, F-/ICT + , F-/ICT-. Age per 5-year increase (OR = 1.27, CI: 1.02-1.55, p = 0.022), nadir CD4 cell count (OR = 0.81, CI: 0.66 - 0.99, p = 0.042) and polypharmacy (OR = 3.47, CI: 2.00 - 6.00, p<0.001) were associated with CF after adjustment for time since HIV diagnosis, multimorbidity, depression and cumulative exposure to dolutegravir.
Conclusion: CF prevalence in PWH >50 years was 6.8% and it is higher than what has been observed in the general population >65 years (1-4.4%). Nadir CD4 cell count and polypharmacy was associated with CF, suggesting an HIV specific contribution related to the development of this condition.
期刊介绍：
Publishing the very latest ground breaking research on HIV and AIDS. Read by all the top clinicians and researchers, AIDS has the highest impact of all AIDS-related journals. With 18 issues per year, AIDS guarantees the authoritative presentation of significant advances. The Editors, themselves noted international experts who know the demands of your work, are committed to making AIDS the most distinguished and innovative journal in the field. Submitted articles undergo a preliminary review by the editor. Some articles may be returned to authors without further consideration. Those being considered for publication will undergo further assessment and peer-review by the editors and those invited to do so from a reviewer pool.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
